Effects of morphine and D-Ala2-D-Leu5-enkephalin in the seizure-susceptible El mouse.
Opioid agonists were used to investigate the modulation of seizures in the seizure-susceptible El mouse. Morphine and D-Ala2-D-Leu5-enkephalin (DADLE) were injected subcutaneously or intracisternally as prototypic agonists for mu and delta opioid receptors. Systemic or intracisternal injection of both morphine and DADLE decreased the incidence of seizures and the seizure score in El mice in a dose-dependent manner. The anticonvulsant effects of morphine and DADLE were reversed by naloxone (2 mg/kg, s.c.). This implies that opioid agonists have anticonvulsant properties which are mediated by mu and delta opioid receptors. In conclusion, a deficit in endogenous opioid peptides, which act as anticonvulsants may play a significant role in the etiology or pathophysiology of seizures in the El mouse.
Koide
S
S
Department of Neuropsychiatry, Osaka City University Medical School, Japan.
Onishi
H
H
Yamagami
S
S
Kawakita
Y
Y
D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D016308:Enkephalin, Leucine-2-Alanine / Q000627:therapeutic use*; D051379:Mice; D008817:Mice, Mutant Strains; D009020:Morphine / Q000627:therapeutic use*; D009270:Naloxone / Q000494:pharmacology; D011957:Receptors, Opioid / Q000502:physiology; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D012640:Seizures / Q000188:drug therapy*
D000927:Anticonvulsants; D011957:Receptors, Opioid; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D009270:Naloxone; D016308:Enkephalin, Leucine-2-Alanine; D009020:Morphine